Sandra is a Research Fellow at the University of Auckland, and her research focuses on developing highly sensitive technologies for the detection of circulating tumour DNA (ctDNA) in the blood of cancer patients. She collaborates extensively with researchers and oncologists from all over New Zealand to drive the translation of minimally invasive liquid biopsy technologies into clinical implementation.